141 filings
Page 3 of 8
8-K
q4if 0j3s
8 Apr 19
Other Events
7:11am
8-K
lej277a x0cjsp4fl0
27 Feb 19
Audentes Therapeutics Reports Fourth Quarter 2018 and Full Year Financial Results and Provides Corporate Update
12:00am
S-8
b3yh8cvrcfj5tkbv3
6 Nov 18
Registration of securities for employees
5:00pm
8-K
w9yf9opgvr
6 Nov 18
Audentes Therapeutics Reports Third Quarter 2018 Financial Results and Provides Corporate Update
12:00am
8-K
f0om3fhuc
11 Oct 18
Audentes Therapeutics Announces Pricing of Public Offering of Common Stock
4:24pm
424B5
stahuor7u
11 Oct 18
Prospectus supplement for primary offering
4:15pm
424B5
1u821 pwf5z8prz
9 Oct 18
Prospectus supplement for primary offering
4:28pm
8-K
4rd1j2icd dsvq2
5 Oct 18
Regulation FD Disclosure
8:05am
UPLOAD
2b18g8qf3xyt
11 Sep 18
Letter from SEC
12:00am
CORRESP
b2px8k62mn2 k59a3
10 Aug 18
Correspondence with SEC
12:00am
8-K
1hjd a6ywjiq7mk8k9
7 Aug 18
Results of Operations and Financial Condition
6:05am
UPLOAD
eghu e9fl4fbli6vb8t
6 Aug 18
Letter from SEC
12:00am
8-K
ljcy3k
8 Jun 18
Submission of Matters to a Vote of Security Holders
5:15pm
8-K
86siom7
16 May 18
Significant improvements in neuromuscular and respiratory function at 24-week timepoint
11:31am